High glucose concentrations attenuate hypoxia-inducible factor-1α expression and signaling in non-tumor cells

Experimental Cell Research

Volumn 316, Issue 7, 2010, Pages 1179-1189

  Dehne, Nathalie ^a   Hintereder, Gudrun ^b   Brüne, Bernhard ^a  

^a Institute of Biochemistry I/ZAFES   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Glutamine; Non tumor cells; Prolyl hydroxylase; Tumor cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENOMEDULLIN; AMINO ACID; FATTY ACID; GLUCOSE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID; MESSENGER RNA; OXOACID; OXOGLUTARIC ACID; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MACROPHAGE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 77950628758     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.02.019     Document Type: Article

References (44)

1. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
2. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007, 274:1393-1418.
3. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 2008, 8:705-713.
4. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
5. Mason S.D., Howlett R.A., Kim M.J., Olfert I.M., Hogan M.C., McNulty W., Hickey R.P., Wagner P.D., Kahn C.R., Giordano F.J., Johnson R.S. Loss of skeletal muscle HIF-1alpha results in altered exercise endurance. PLoS Biol. 2004, 2:e288.
6. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.P., Ferrara N., Johnson R.S. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657.
7. Kwon S.J., Lee Y.J. Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin. Cancer Res. 2005, 11:4694-4700.
8. Lu H., Dalgard C., Mohyeldin A., McFate T., Tait A.S., Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 2005, 280:41928-41939.
9. Vordermark D., Kraft P., Katzer A., Bolling T., Willner J., Flentje M. Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Cancer Lett. 2005, 230:122-133.
10. Lu H., Forbes R.A., Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 2002, 277:23111-23115.
11. Dehne N., Kerkweg U., Otto T., Fandrey J. The HIF-1 response to simulated ischemia in mouse skeletal muscle cells neither enhances glycolysis nor prevents myotube cell death. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1693-R1701.
12. Catrina S.B., Okamoto K., Pereira T., Brismar K., Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 2004, 53:3226-3232.
13. Gao W., Ferguson G., Connell P., Walshe T., Murphy R., Birney Y.A., O'Brien C., Cahill P.A. High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. J. Mol. Cell Cardiol. 2007, 42:609-619.
14. Malhotra R., Tyson D.G., Sone H., Aoki K., Kumagai A.K., Brosius F.C. Glucose uptake and adenoviral mediated GLUT1 infection decrease hypoxia-induced HIF-1alpha levels in cardiac myocytes. J. Mol. Cell Cardiol. 2002, 34:1063-1073.
15. Von Knethen A.A., Brune B. Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages. FASEB J. 2001, 15:535-544.
16. 2 and NO concentrations in NO-induced cell death in a rat liver sinusoidal endothelial cell line. Biol. Chem. 2004, 385:341-349.
17. Hagen T., Taylor C.T., Lam F., Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 2003, 302:1975-1978.
18. Jennewein C., Kuhn A.M., Schmidt M.V., Meilladec-Jullig V., von Knethen A., Gonzalez F.J., Brune B. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J. Immunol. 2008, 181:5646-5652.
19. Doege K., Heine S., Jensen I., Jelkmann W., Metzen E. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 2005, 106:2311-2317.
20. Smith A.R., Visioli F., Hagen T.M. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J. 2002, 16:1102-1104.
21. Mayevsky A., Rogatsky G.G. Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies. Am. J. Physiol. Cell Physiol. 2007, 292:C615-C640.
22. Hewitson K.S., Lienard B.M., McDonough M.A., Clifton I.J., Butler D., Soares A.S., Oldham N.J., McNeill L.A., Schofield C.J. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J. Biol. Chem. 2007, 282:3293-3301.
23. Seagroves T.N., Ryan H.E., Lu H., Wouters B.G., Knapp M., Thibault P., Laderoute K., Johnson R.S. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell Biol. 2001, 21:3436-3444.
24. Botusan I.R., Gupta Sunkari V., Savu O., Catrina A.I., Grunler J., Lindberg S., Pereira T., Yla-Herttuala S., Poellinger L., Brismar K., Catrina S.B. Stabilization of HIF-1{alpha} is critical to improve wound healing in diabetic mice. Proc. Natl. Acad. Sci. U S A 2008, 105:19426-19431.
25. Rodriguez-Enriquez S., Juarez O., Rodriguez-Zavala J.S., Moreno-Sanchez R. Multisite control of the Crabtree effect in ascites hepatoma cells. Eur. J. Biochem. 2001, 268:2512-2519.
26. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid. Redox Signal 2007, 9:931-942.
27. Heywood H.K., Bader D.L., Lee D.A. Rate of oxygen consumption by isolated articular chondrocytes is sensitive to medium glucose concentration. J. Cell Physiol. 2006, 206:402-410.
28. Dalgard C.L., Lu H., Mohyeldin A., Verma A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem. J. 2004, 380:419-424.
29. Pan Y., Mansfield K.D., Bertozzi C.C., Rudenko V., Chan D.A., Giaccia A.J., Simon M.C. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol. Cell Biol. 2007, 27:912-925.
30. Matsumoto K., Imagawa S., Obara N., Suzuki N., Takahashi S., Nagasawa T., Yamamoto M. 2-oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1alpha and inhibits angiogenesis. J. Cell Physiol. 2006, 209:333-340.
31. MacKenzie E.D., Selak M.A., Tennant D.A., Payne L.J., Crosby S., Frederiksen C.M., Watson D.G., Gottlieb E. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell Biol. 2007, 27:3282-3289.
32. Zhao S., Lin Y., Xu W., Jiang W., Zha Z., Wang P., Yu W., Li Z., Gong L., Peng Y., Ding J., Lei Q., Guan K.L., Xiong Y. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009, 324:261-265.
33. Mailloux R.J., Puiseux-Dao S., Appanna V.D. Alpha-ketoglutarate abrogates the nuclear localization of HIF-1alpha in aluminum-exposed hepatocytes. Biochimie 2009, 91:408-415.
34. Effert P., Beniers A.J., Tamimi Y., Handt S., Jakse G. Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma. Anticancer Res 2004, 24:3057-3063.
35. Lawson M.A., Purslow P.P. Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs 2000, 167:130-137.
36. Meissner J.D., Umeda P.K., Chang K.C., Gros G., Scheibe R.J. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway. J. Cell Physiol. 2007, 211:138-148.
37. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., Thompson C.B. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U S A 2007, 104:19345-19350.
38. Marfella R., Esposito K., Nappo F., Siniscalchi M., Sasso F.C., Portoghese M., Di Marino M.P., Baldi A., Cuzzocrea S., Di Filippo C., Barboso G., Baldi F., Rossi F., D'Amico M., Giugliano D. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 2004, 53:2383-2391.
39. Mace K.A., Yu D.H., Paydar K.Z., Boudreau N., Young D.M. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen 2007, 15:636-645.
40. Thangarajah H., Yao D., Chang E.I., Shi Y., Jazayeri L., Vial I.N., Galiano R.D., Du X.L., Grogan R., Galvez M.G., Januszyk M., Brownlee M., Gurtner G.C. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc. Natl. Acad. Sci. U S A 2009, 106:13505-13510.
41. Aprelikova O., Wood M., Tackett S., Chandramouli G.V., Barrett J.C. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 2006, 66:5641-5647.
42. Marfella R., D'Amico M., Di Filippo C., Piegari E., Nappo F., Esposito K., Berrino L., Rossi F., Giugliano D. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002, 45:1172-1181.
43. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., Hankinson O., Pugh C.W., Ratcliffe P.J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. U S A 1997, 94:8104-8109.
44. Kimura Y., Sumiyoshi M. High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice. Nutr. Cancer 2007, 59:207-216.